Let's work together to make connections


Together, we may help connect the right people to the right treatments faster.

Contact us

Sponsored genetic testing may help healthcare providers quickly and more accurately diagnose patients—and, in many cases, identify the treatment or therapy most likely to succeed.

(Photo: Naya Edouard)

Meet Naya

Two years after she started missing developmental milestones—and nearly a year after a neurologist first suggested genetic testing—Naya finally has a diagnosis thanks to the Behind the Seizure® sponsored testing program.
“Naya is such a happy child,” says Naya’s mom, Alexis. “Now we can accept where we are and not worry about when she’ll catch up. Now we can move forward.”

Sponsored testing program highlight:
Behind the Seizure®

“More than half of epilepsies are based in genetics. When a child experiences a seizure, performing genetic testing quickly using a comprehensive gene panel is a highly cost-effective and informative diagnostic tool,” says Dr. Robert Nussbaum, Invitae’s chief medical officer. “Quickly finding an underlying cause for infantile epilepsy can be crucial for making a difference for that patient with precision management and treatment options.”
The Behind the Seizure® sponsored program demonstrates the power of collaboration among biopharma companies and has become a template for how partnerships like this can support accelerating diagnosis at scale.

How does sponsored testing work?

  • Partners provide financial support for the testing to offer genetic testing at no charge to patients who meet medical criteria
  • Patients and clinicians don’t bear the burden of navigating uncertain insurance reimbursement for testing
  • Partners receive de-identified variant and clinical information as well as contact information for healthcare providers who order through the program.*

Genetic testing with Invitae

Making genetic testing accessible to patients and their clinicians is at the core of Invitae’s mission to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Our clinical-grade tests are CLIA and CAP certified.

Over 1,000,000 patients tested

Over 100 biopharma programs

More than 20 sponsored testing programs
*Patient identifiable information is not shared and healthcare providers have no obligation to recommend or prescribe any products or services.
1. Miller, Nicole et al. Behind the Seizure: A no-cost 125-gene epilepsy panel for pediatric seizure onset between 2–4 years. Presented at the American Society of Human Genetics Meeting: October 16–20, 2018, San Diego, CA.
2. Pal DK, Pong AW, Chung WK. Genetic evaluation and counseling for epilepsy. Nat Rev Neurol. 2010;6:445-453.